Intellectual Property Magazine
Broad Institute fails to end CRISPR interference case
Broad says post-PTAB ruling that parties must ‘move beyond litigation’; CVC ‘pleased’ that case will continue
Ben Wodecki
The Broad Institute has been dealt a major blow in the ongoing US patent interference battle over CRISPR/Cas9 technologies,
after the Patent Trial and Appeal Board (PTAB) rejected a motion that sought to prevent the case from proceeding.